![Stephen M. Restaino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen M. Restaino active positions
Companies | Position | Start | End |
---|---|---|---|
Sonosa Medical, Inc.
![]() Sonosa Medical, Inc. Medical SpecialtiesHealth Technology Sonosa Medical, Inc. is a company that is developing the next generation of tools to diagnose and treat obstructive sleep apnea (OSA). The company is based in Baltimore, MD and was founded by Gilmer L. Blankenship, Stephen M. Restaino, and Jeffrey M. Wolf. OSA is a condition that affects nearly 1 billion people worldwide, causing partial or complete airway collapse during sleep, leading to frequent sleep disruptions and poor sleep quality. Sonosa Medical is developing a wearable ultrasound system to fundamentally change how OSA treatments are managed, providing a direct visual of obstructions during normal sleep, so clinicians can select the right treatment the first time. Stephen M. Restaino has been the CEO since incorporation. | Chief Executive Officer | 2019-10-31 | - |
Founder | 2019-10-31 | - |
Career history of Stephen M. Restaino
Statistics
International
United States | 2 |
Operational
Chief Executive Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Sonosa Medical, Inc.
![]() Sonosa Medical, Inc. Medical SpecialtiesHealth Technology Sonosa Medical, Inc. is a company that is developing the next generation of tools to diagnose and treat obstructive sleep apnea (OSA). The company is based in Baltimore, MD and was founded by Gilmer L. Blankenship, Stephen M. Restaino, and Jeffrey M. Wolf. OSA is a condition that affects nearly 1 billion people worldwide, causing partial or complete airway collapse during sleep, leading to frequent sleep disruptions and poor sleep quality. Sonosa Medical is developing a wearable ultrasound system to fundamentally change how OSA treatments are managed, providing a direct visual of obstructions during normal sleep, so clinicians can select the right treatment the first time. Stephen M. Restaino has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Stephen M. Restaino
- Experience